^
BIOMARKER:

MAP2K1 P124Q

i
Other names: MAP2K1, MAPKK1, MEK1, PRKMK1, Mitogen-activated protein kinase kinase 1
Entrez ID:
Related biomarkers:
News
Twitter
Trials
MAP2K1 P124Q
Melanoma
trametinib
Resistant: C3 – Early Trials
MAP2K1 P124Q
Melanoma
dabrafenib
Sensitive: C3 – Early Trials
MAP2K1 P124Q
Melanoma
VTX-11e
Sensitive: D – Preclinical